Terms: = Leukemia AND ARID1B, 6A3-5, 57492, ENSG00000049618, p250R, KIAA1235, ELD/OSA1, DAN15, BRIGHT, BAF250b
395 results:
1. A Bizarre Progression Of Chronic Lymphocytic Leukaemia Into Diffuse Large B-Cell Lymphoma.
Shakeel D; Qadir H; Baig MM; Ojla SM
J Ayub Med Coll Abbottabad; 2023; 35(3):512-514. PubMed ID: 38404107
[TBL] [Abstract] [Full Text] [Related]
2. Glasdegib with intensive/nonintensive chemotherapy in Japanese patients with untreated acute myeloid leukemia or high-risk myelodysplastic syndromes.
Izutsu K; Ubukawa K; Morishita T; Onishi Y; Ishizawa K; Fujii Y; Kimura N; Yokochi M; Naoe T
Cancer Sci; 2024 Apr; 115(4):1250-1260. PubMed ID: 38327103
[TBL] [Abstract] [Full Text] [Related]
3. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
4. The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.
Al-Zubaidi HK; Hughes SF
Br J Biomed Sci; 2023; 80():11573. PubMed ID: 37822353
[No Abstract] [Full Text] [Related]
5. Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 bright AML 1019 trial.
Sekeres MA; Montesinos P; Novak J; Wang J; Jeyakumar D; Tomlinson B; Mayer J; Jou E; Robak T; Taussig DC; Dombret H; Merchant A; Shaik N; O'Brien T; Roh W; Liu X; Ma W; DiRienzo CG; Chan G; Cortes JE
Leukemia; 2023 Oct; 37(10):2017-2026. PubMed ID: 37604981
[TBL] [Abstract] [Full Text] [Related]
6. Acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia accompanying arid1b gene mutation.
Wu D; Gao R
Hematology; 2023 Dec; 28(1):2227495. PubMed ID: 37387408
[TBL] [Abstract] [Full Text] [Related]
7. ZNF384-Related Fusion Genes in Acute Lymphoblastic leukemia.
Zhu L; Bai W; Cheng Q; Fang J
Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
[TBL] [Abstract] [Full Text] [Related]
8. Flow Cytometry of CD5-Positive Hairy Cell leukemia.
Cenariu D; Rus I; Bergthorsson JT; Grewal R; Cenariu M; Greiff V; Tigu AB; Dima D; Selicean C; Petrushev B; Zdrenghea M; Fromm J; Aanei CM; Tomuleasa C
Mol Diagn Ther; 2023 Sep; 27(5):593-599. PubMed ID: 37291380
[TBL] [Abstract] [Full Text] [Related]
9. Acute myeloid leukemia with RAM immunophenotype: A new underdiagnosed entity.
Gajendra S; Anupurba S; Gupta R; Mallick S; Panda D; Thakral D; Gupta SK; Bakhshi S; Seth R; Rai S; Prajapati VK; Singh S
Int J Lab Hematol; 2023 Aug; 45(4):541-552. PubMed ID: 37078511
[TBL] [Abstract] [Full Text] [Related]
10. Opportunities for CAR-T Cell Immunotherapy in HIV Cure.
Campos-Gonzalez G; Martinez-Picado J; Velasco-Hernandez T; Salgado M
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992496
[TBL] [Abstract] [Full Text] [Related]
11. Production and applications of fluorobody from redox-engineered Escherichia coli.
Srila W; Min TT; Sumphanapai T; Rangnoi K; Berkmen M; Yamabhai M
Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1959-1970. PubMed ID: 36729226
[TBL] [Abstract] [Full Text] [Related]
12. A Flow Cytometry Panel for Differential Diagnosis of Mantle Cell Lymphoma from Atypical B-Chronic Lymphocytic Leukaemia.
Mehrpouri M; Sadat Hosseini M; Jafari L; Mosleh M; Shahabi Satlsar E
Iran Biomed J; 2023 Jan; 27(1):15-22. PubMed ID: 36624655
[TBL] [Abstract] [Full Text] [Related]
13. Phenotypic and functional characterisation of locally produced natural killer cells ex vivo expanded with the K562-41BBL-mbIL21 cell line.
Shman TV; Vashkevich KP; Migas AA; Matveyenka MA; Lasiukov YA; Mukhametshyna NS; Horbach KI; Aleinikova OV
Clin Exp Med; 2023 Oct; 23(6):2551-2560. PubMed ID: 36527513
[TBL] [Abstract] [Full Text] [Related]
14. Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors.
Fang H; Wang SA; You MJ; Hu S; Miranda RN; Tang Z; Lin P; Jorgensen JL; Xu J; Thakral B; Schlette EJ; El Hussein S; Bueso-Ramos C; Medeiros LJ; Wang W
Cytometry B Clin Cytom; 2022 Nov; 102(6):440-447. PubMed ID: 36156384
[TBL] [Abstract] [Full Text] [Related]
15. KIF23 promotes autophagy-induced imatinib resistance in chronic myeloid leukaemia through activating Wnt/β-catenin pathway.
Huang Y; Yuan C; Liu Q; Wang L
Clin Exp Pharmacol Physiol; 2022 Dec; 49(12):1334-1341. PubMed ID: 36066385
[TBL] [Abstract] [Full Text] [Related]
16. A bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies.
Newman H; Teachey DT
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955734
[TBL] [Abstract] [Full Text] [Related]
17. Dark genome, bright ideas: Recent approaches to harness transposable elements in immunotherapies.
Reid Cahn A; Bhardwaj N; Vabret N
Cancer Cell; 2022 Aug; 40(8):792-797. PubMed ID: 35907399
[TBL] [Abstract] [Full Text] [Related]
18. The prognostic role of NKG2A expression for patients with chronic myeloid leukemia after treatment discontinuation.
Xu Z; Yin J; Sun Q; Hu J; Hong M; Qian S; Liu W
Leuk Lymphoma; 2022 Nov; 63(11):2616-2626. PubMed ID: 35758278
[TBL] [Abstract] [Full Text] [Related]
19. Higher Dose of CD34
Zhao F; Shi Y; Chen X; Zhang R; Pang A; Zhai W; Yang D; He Y; Feng S; Zhang P; Jiang E; Han M
Transplant Cell Ther; 2022 Sep; 28(9):589.e1-589.e10. PubMed ID: 35714907
[TBL] [Abstract] [Full Text] [Related]
20. Single-cell RNA sequencing to explore composition of peripheral blood NK cells in patients with chronic myeloid leukemia in treatment-free remission.
Yu G; Lu W; Chen X; Li Y; Long J; Zheng Z; Yin C; Xu D
Leuk Lymphoma; 2022 Nov; 63(11):2604-2615. PubMed ID: 35695125
[TBL] [Abstract] [Full Text] [Related]
[Next]
